Abiopharma

IsoEnergy Completes Acquisition of Toro Energy

Triple Flag Completes Acquisition of US$440 Million Gold Stream on the Ravenswood Gold Mine

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

General Announcement: Early Termination of Lease at Concor Park Campus

AMC Entertainment Holdings, Inc. Announces Closing of $200 Million Registered Direct Offering of Common Stock

High Templar Tech Announces Preliminary Results of Modified Dutch Auction Tender Offer

Additional extension of the memorandum of understanding between Delek Israel and HOT Mobile until June 30, 2026

Share Buy Back - Daily Share Buy-Back Notice: Share Buy Back - Daily Share Buy-Back Notice

KKR Announces Intra-Quarter Update

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10)Advanced Triple-Negative Breast Cancer (TNBC)